Repligen (REGN) announced that it has appointed Jason Garland as Chief Financial Officer, CFO, effective September 25, 2023. Garland is joining Repligen from his most recent role with medical device outsource, MDO, manufacturer Integer Holdings (ITGR), where he served for nearly five years as Executive Vice President and CFO. He succeeds retiring CFO Jon Snodgres, who joined the Company in June 2014 and will continue in a full-time advisory role until his October 6, working closely with Garland to ensure a smooth transition.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RGEN:
- Repligen management to meet with Stephens
- Repligen Corporation to Present at Wells Fargo Healthcare Conference
- Repligen, Sartorius launch integrated system with Biostat STR
- Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification
- Repligen price target lowered to $200 from $207 at Craig-Hallum